Latest Biotechnology, Pharmaceutical and Healthcare News

01:32 EDT 17th September 2014 | BioPortfolio

Showing News Articles 1–25 of 650,000+

Wednesday 17th September 2014

Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress

- Data Accepted for Inclusion in the Presidential Symposium 2 on Monday, September 29, 2014 - Exelixis, Inc. (NASDAQ:EXEL) today announced that cobimetinib, an Exelixis-discovered compound, will be the subject of a clinical data presentation at the European Society for Medical Oncology (ESMO) 2014 Congress. During the meeting, which will be held from S...

ASBMR 2014: Four bone drug updates, including Merck's odanacatib

A review of long-term impacts of treatment with Amgen's approved bone drug Prolia (denosumab) for postmenopausal women with osteoporosis also was presented during the conference.

BeiGene Books $9 Million Milestone from Merck Serono

BeiGene, a Beijing novel drug developer, received a $9 million milestone from Merck Serono for starting a Phase I trial of BGB-290, a second generation PARP inhibitor. Less than a year ago, Merck Serono and BeiGene entered a co-development agreement ...

Lord Drayson talking “driving health and growth” at UK Bioscience Forum

The UK BioIndustry Association (BIA) is delighted to welcome Lord Drayson to speak at its award-winning UK Bioscience Forum on 7th October 2014 which is taking place during European Biotech Week.A key driver behind the formation of the Office for Lif...

Food companies' U.S. calorie-cutting pledge could stall: researchers

NEW YORK (Reuters) - A campaign by 16 of the world's largest food and beverage companies to dramatically cut the number of calories sold in the United States may have stalled after initial success, researchers reported on Wednesday.

Tuesday 16th September 2014

Nature’s designs inspire research into new light-based technologies

Solutions required for progress on the frontiers of photonics technology are close at hand: in nature, when viewed through the perspective of engineer, says Montana State University optics researcher Joseph Shaw. Along with Rongguang Liang of the University of Arizona, Shaw chaired the “Light in Nature” conference presenting new research in the field last month at SPIE Optics + Photonics and b...

GAO report warns of security risks in U.S. healthcare website

(Reuters) -, President Barack Obama's health insurance exchange, has security and privacy protection vulnerabilities, a U.S. government watchdog reported on Tuesday, nearly a year after the website's troubled rollout.

Civitas Solutions, Inc. Announces Pricing of Initial Public Offering

Civitas Solutions, Inc. (“Civitas” or the “Company”) announced today that it has priced the underwritten initial public offering of 11,700,000 shares of its common stock at a price to the public of $17.00 per share. In connection with the offering, Civitas has granted the underwriters a 30-day option to purchase up to an additional 1,755,000 shares...

UPDATE 2-Endo's $2.2 bln offer could complicate Auxilium Pharma's QLT deal

Sept 16 (Reuters) - Endo International Plc made an unsolicited offer to buy Auxilium Pharmaceuticals Inc for about $2.2 billion, which analysts said could complicate Auxilium's buyout of Canadian eye drug maker QLT Inc .

09.16.14 -- Acadia Drug Named Breakthrough Therapy; Lessons Learned: 10 Years Of Tech Transfers

09/16/14 Pharmaceutical Online Newsletter

Micromeritics To Participate In University Of Maryland Tableting Course

This October, the University of Maryland School of Pharmacy will hold its second annual Tablets & Capsules Hands-On Short Course.

Australia's booming aged-care sector set for unprecedented shakeup

SYDNEY, Sept 17 (Reuters) - Australian aged care is about to become big business as investors rush for a slice of a rapidly growing $10 billion industry, seeking funding to buy rivals and build nursing homes in one of the fastest-aging societies in t...

Research findings could help explain how some people stave off dementia

The human brain is capable of a neural workaround that compensates for the buildup of beta-amyloid, a destructive protein associated with Alzheimer's disease, according to a new study led by researchers at the University of California, Berkeley.

Missing paperwork puts coverage at risk for tens of thousands of people

According to the Obama administration, as many as 115,000 people could lose the new insurance they obtained under the health law because they did not prove they were legal immigrants or U.S. citizens who were eligible for that coverage. Another 363,0...

Study: Marijuana users may attempt to manage negative moods by using drug

Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug, according to a study in September's Journal of Studies on Alcohol and Drugs.

Positive messages more effective at persuading smokers to quit

Which is more likely to convince a smoker to quit? The words, "Warning: cigarettes cause cancer" beneath the image of an open mouth with a cancerous lesion and rotten teeth, or the same image with the words, "Warning: Quitting smoking reduces the ris...

Breast cancer screening in older women leads to overdiagnosis, say researchers

Instead, it may just lead to overdiagnosis and overtreatment, suggest the researchers, led by a team based at Leiden University Medical Centre in the Netherlands.

3SBio signs exclusive license agreement with JenKem for PEG-irinotecan

3SBio Inc., a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered into an exclusive license agreement with JenKem Technology Co....

Pacific Northwest Provenance Hotels Offer Charitable Room Rates, Signature Bracelets and Pink Cocktails Benefitting Keep A Breast During National Breast Cancer Month

Seattle's Hotel Max and Portland's Hotel Lucia, Hotel deluxe and Sentinel invite travelers to help raise funds and awareness for Keep A Breast programs that use art, creative expression and grassroots action to inform young people about methods of prevention, early detection, coping and support. Portland, OR (PRWEB) September 16, 2014 This October during National Breast Cancer Month, Prov...

WRAPUP 6-Citing security threat, Obama expands U.S. role fighting Ebola

* Defense Dept seeks to reallocate up to $1 bln from prior year

GLP’s Jon Entine cautions National Academy of Sciences about views of anti-science NGOs | Genetic Literacy Project

Jon Entine's testimony:EDITOR’S NOTE: The National Research Council of the National Academy of Sciences held two days of discussions this week on the controversial issue of crop biotechnology as it collects information for a spring 2016 report. Below are the remarks on September 16 from one of the invitees: Jon Entine of the GLP.I’m Jon Entine, executive director of the Genetic Literacy Projec...

[Articles] Apgar score and the risk of cause-specific infant mortality: a population-based cohort study

Low Apgar score at 5 min was strongly associated with the risk of neonatal and infant death. Our findings support its continued usefulness in contemporary practice.

[Comment] Neonatal and infant death: the Apgar score reassessed

Apgar scores are used to convey information about newborn infants' transition to an extrauterine environment. In The Lancet, Stamatina Iliodromiti and colleagues present a well-executed study to determine if previously recognised associations between...

Meeting the Challenges of Excipient Variability

The quality and composition of excipients can vary due to environmental factors, processing methods, raw material quality, manufacturing location changes, and even operator actions.

FDA Approves Treatment for Children with Hemophilia B

FDA approved Baxter International's treatment, RIXUBIS, for the treatment of children with hemophilia B.

Search BioPortfolio:

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.